New insight into the effect of hydroxychloroquine undermines its use in COVID-19

New insight into the effect of hydroxychloroquine undermines its use in COVID-19
Credit: Cell Reports Medicine

Researchers at Radboud university medical center have discovered an as yet unknown effect of hydroxychloroquine. It inhibits the action of a type of white blood cells important in the first line of defense against infections. Based on this research, hydroxychloroquine is unlikely to be beneficial in clearing viral infections including the new coronavirus SARS-CoV-2, they write in their publication in Cell Reports Medicine.

Hydroxychloroquine is an agent that has been used for years, originally for the treatment of malaria. It is also widely used to treat patients with , because has immunomodulatory effects. It is not known exactly how hydroxychloroquine does this. Hydroxychloroquine use for COVID-19 remains a topic of intense debate and investigation. Especially in the context of their use as a prophylaxis, large studies are ongoing to investigate their efficacy.

Rapid action

In a virus infection, such as the new coronavirus SARS-CoV-2, a good response from the is essential for fighting the virus. If the immune response in the beginning of the infection is insufficient, the virus can spread and cause damage. This uncontrolled infection, which sometimes leads to serious illness or death with SARS-CoV-2, is exactly what you want to prevent.

First responders

Raphaël Duivenvoorden, internist-nephrologist at Radboud university , "We looked at the immune response of patients admitted to the hospital with a SARS-CoV-2 infection. We observed that a certain type of immune cells, the monocytes, play an important role in the first line of defense against the coronavirus. Therefore, we investigated the effect of hydroxychloroquine on these cells.

Impaired defense

Monocytes can develop a type of nonspecific memory, something called 'trained immunity.' Thanks to this mechanism, monocytes are able to develop a stronger response to bacteria and viruses. In this way, monocytes can contribute to a better and earlier control of invaded micro-organisms. Duivenvoorden, who coordinated the study: "We found that hydroxychloroquine prevents the development of this protective mechanism of "trained immunity". That is why we expect hydroxychloroquine to have no beneficial effect on the in a SARS-CoV-2 infection.

More information: Nils Rother et al, Hydroxychloroquine Inhibits the Trained Innate Immune Response to Interferons, Cell Reports Medicine (2020). DOI: 10.1016/j.xcrm.2020.100146

Provided by Radboud University
Citation: New insight into the effect of hydroxychloroquine undermines its use in COVID-19 (2020, November 23) retrieved 21 March 2023 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Follow the latest news on the coronavirus (COVID-19) outbreak


Feedback to editors